Episode

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

Podcast: Hematologic Oncology Update
Published: Feb 13, 2026
Duration seconds: 1038
Processing state: not_requested
Canonical source: https://hematologic-oncology.captivate.fm/episode/5918-ashrrmm25-micro-2
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/dcbf2674-4d30-4272-ba52-8692ac13aca8.mp3
JSON: /v1/public/podcasts/hematologic-oncology-update-916423/episodes/relapsed-refractory-multiple-myeloma-microlearning-activity-2-with-dr-sagar-lonial-ash-2025-review
Markdown: /podcast/hematologic-oncology-update-916423/relapsed-refractory-multiple-myeloma-microlearning-activity-2-with-dr-sagar-lonial-ash-2025-review.md

Actions

POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/relapsed-refractory-multiple-myeloma-microlearning-activity-2-with-dr-sagar-lonial-ash-2025-review/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/hematologic-oncology-update-916423/relapsed-refractory-multiple-myeloma-microlearning-activity-2-with-dr-sagar-lonial-ash-2025-review.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025. CME information and select publications here .